OBN Press Releases

 

OBN Announce the 2020 OBN Award winners

14 June 2021 - Rebecca Wilkes

We are delighted to announce the winners of the prestigious 2020 OBN Awards, presented on Friday 11 June at the Royal Lancaster in London. The Awards, which are in their 12th year, shine a light on companies at all stages of development, recognising inspirational leadership, exciting innovation, novel and exciting approaches to unmet clinical need, outstanding company progression and the delivery of real-life tangible results.  The OBN Awards celebrate...

Read More

OBN and its Investment & Tax Special Interest Group (ITSIG) issues an Open Letter to the Chancellor for a better deal for the Life Sciences sector

29 March 2021 - Rebecca Wilkes

OBN and its Investment & Tax Special Interest Group (ITSIG) issues an Open Letter to the Chancellor for a better deal for the Life Sciences sector   OBN and ITSIG have contacted Mr Sunak about the Business Asset Disposal Relief (BADR) (formerly Entrepreneurs’ Relief), with new proposals as we do not believe that in its current form it represents the best interests of the UK industry, its employees, or investors. OBN and ITSIG have therefore...

Read More

OBN Announces FOCUS Oxford Risk Management Ltd and Partners& as New OBN Corporate Sponsor

09 March 2021 - Rebecca Wilkes

Abingdon, UK; 9 March 2021 - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce FOCUS Oxford Risk Management Ltd and Partners& as OBN’s new Corporate Sponsor. FOCUS is an independent insurance broker providing specialist advice to both business and private clients.  FOCUS has been providing specialist insurance over 30 years and in January 2021 became part of Partners&.  Partners&...

Read More

OBN CEO Update: John Harris, CEO, reflects on 2020 and looks forward to 2021

02 December 2020 - Rebecca Wilkes

CEO Update by John Harris, CEO, OBN It goes without saying that 2020 has proven to be very challenging on many fronts with repeated lockdowns and restrictions impacting individuals, companies, and the economy as a whole. There does, however, appear to be some optimism, especially with the great news today that the UK is the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine which can start to be used as early as...

Read More

OBN Announce AggioSergeant as a New Corporate Sponsor

04 November 2020 - Rebecca Wilkes

Abingdon, UK; 4 November - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce AggioSergeant as OBN’s new Corporate Sponsor. AggioSergeant is an international boutique retained search firm that has been delivering life science leadership and connecting extraordinary businesses to outstanding people for more than 30 years. Working globally, they have an unparalleled network within the life...

Read More

OBN: CEO Update from John Harris

21 September 2020 - Rebecca Wilkes

CEO Update by John Harris, CEO, OBN   As the country returns to some semblance of normality, despite the recent guidelines, I’d like to take the opportunity to bring our Members, Sponsors and Supporters up to date with the world of OBN.  OBN responded quickly and decisively to the unprecedented challenge that COVID 19, the lockdown and subsequent restrictions brought and I am delighted and proud of the OBN team’s response to such extraordinary...

Read More

OBN Awards 2020 - Finalists Announced!

09 September 2020 - Rebecca Wilkes

We are pleased to announce details of the companies that have been shortlisted to the final round of the 12th Annual OBN Awards, the most highly regarded awards event in the life sciences industry.     Entry numbers were up again this year, and the first-round judges were impressed by the overall quality of the entries received and the number of new companies entering.  Of particular note is the number of entries received in the ‘Best Established...

Read More

OBN Launch OBN Ventures™ An Investment Lifeline in Challenging Times

28 April 2020 - Rebecca Wilkes

Abingdon, UK; 28 April 2020 - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is delighted to announce the launch of OBN Ventures Limited (OBNV). OBNV is a wholly owned subsidiary of OBN (UK) Ltd, and offers a sophisticated FCA-approved on-line investment platform, provided by Envestors Ltd, which is designed to bring a wide range of investors together with early-stage life sciences and related companies...

Read More

A message from John Harris, CEO of OBN re BioTrinity 2020 & COVID-19

19 March 2020 - Rebecca Wilkes

Following the most recent announcements by the Prime Minister in the UK, a Force Majeure situation has been created whereby delivering BioTrinity® as a physical event has now become an impossibility. We will continue to follow all official UK Government and Public Health England advice. The safety, security and interests of our staff, Members and our wider network remains our absolute priority. BioTrinity is responsible for a very high proportion...

Read More

OBN Awards 2019 – Winners Recognised at Industry Leading Event

08 November 2019 - Rebecca Wilkes

Abingdon, UK, 8 November 2019: – OBN (UK) Ltd., the membership organisation that supports the life sciences industry, is delighted to announce the winners of the 2019 OBN Awards. The Awards, which are in their 11th year, celebrate the best of UK life sciences – from outstanding scientific innovation within Biotech, Medtech and Digital Health, to the companies that support the industry and the fundraisers that make it happen.  This year’s event...

Read More

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.